About this document

SARS-CoV-2 Vaccine for Juvenile Cats by amorimpeixotoml is a document available to read on EtoBox.

This research evaluates a spike protein-based subunit SARS-CoV-2 vaccine for juvenile cats, focusing on its safety, immunogenicity, and protective efficacy. The study involved 16 kittens divided into four groups receiving different vaccine formulations, with results showing that both adjuvanted vaccines induced strong immune responses and protected against viral replication. These findings suggest the potential for this vaccine to prevent SARS-CoV-2 transmission in cats.

Author

amorimpeixotoml

Language

EN